Literature DB >> 12600711

Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety.

David L Walker1, Donna J Toufexis, Michael Davis.   

Abstract

The bed nucleus of the stria terminalis is a limbic forebrain structure that receives heavy projections from, among other areas, the basolateral amygdala, and projects in turn to hypothalamic and brainstem target areas that mediate many of the autonomic and behavioral responses to aversive or threatening stimuli. Despite its strategic anatomical position, initial attempts to implicate the bed nucleus of the stria terminalis in conditioned fear were largely unsuccessful. Recent studies have shown, however, that the bed nucleus of the stria terminalis does participate in certain types of anxiety and stress responses. In this work, we review these findings and suggest from the emerging pattern of evidence that, although the bed nucleus of the stria terminalis may not be necessary for rapid-onset, short-duration behaviors which occur in response to specific threats, the bed nucleus of the stria terminalis may mediate slower-onset, longer-lasting responses that frequently accompany sustained threats, and that may persist even after threat termination.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12600711     DOI: 10.1016/s0014-2999(03)01282-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  323 in total

1.  Presynaptic muscarinic M(2) receptors modulate glutamatergic transmission in the bed nucleus of the stria terminalis.

Authors:  Ji-Dong Guo; Rimi Hazra; Joanna Dabrowska; E Chris Muly; Jürgen Wess; Donald G Rainnie
Journal:  Neuropharmacology       Date:  2011-12-08       Impact factor: 5.250

2.  Investigation of a central nucleus of the amygdala/dorsal raphe nucleus serotonergic circuit implicated in fear-potentiated startle.

Authors:  B M Spannuth; M W Hale; A K Evans; J L Lukkes; S Campeau; C A Lowry
Journal:  Neuroscience       Date:  2011-01-26       Impact factor: 3.590

3.  Alcohol stress response dampening: selective reduction of anxiety in the face of uncertain threat.

Authors:  Kathryn R Hefner; John J Curtin
Journal:  J Psychopharmacol       Date:  2011-09-21       Impact factor: 4.153

4.  Effects of the beta-blocker propranolol on cued and contextual fear conditioning in humans.

Authors:  Christian Grillon; Jeremy Cordova; Charles Andrew Morgan; Dennis S Charney; Michael Davis
Journal:  Psychopharmacology (Berl)       Date:  2004-09       Impact factor: 4.530

Review 5.  Cannabinoid modulation of noradrenergic circuits: implications for psychiatric disorders.

Authors:  Ana Franky Carvalho; Elisabeth J Van Bockstaele
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-01-24       Impact factor: 5.067

6.  Prefrontal cortical contributions during discriminative fear conditioning, extinction, and spontaneous recovery in rats.

Authors:  Erin L Zelinski; Nancy S Hong; Amanda V Tyndall; Brett Halsall; Robert J McDonald
Journal:  Exp Brain Res       Date:  2010-05-07       Impact factor: 1.972

Review 7.  Hindbrain noradrenergic A2 neurons: diverse roles in autonomic, endocrine, cognitive, and behavioral functions.

Authors:  Linda Rinaman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-10-20       Impact factor: 3.619

Review 8.  Anteroventral bed nuclei of the stria terminalis neurocircuitry: Towards an integration of HPA axis modulation with coping behaviors - Curt Richter Award Paper 2017.

Authors:  Jason J Radley; Shane B Johnson
Journal:  Psychoneuroendocrinology       Date:  2017-12-24       Impact factor: 4.905

9.  Injured brain regions associated with anxiety in Vietnam veterans.

Authors:  Kristine M Knutson; Shana T Rakowsky; Jeffrey Solomon; Frank Krueger; Vanessa Raymont; Michael C Tierney; Eric M Wassermann; Jordan Grafman
Journal:  Neuropsychologia       Date:  2013-01-15       Impact factor: 3.139

10.  PACAP in the BNST produces anorexia and weight loss in male and female rats.

Authors:  Margaret Kocho-Schellenberg; Kimberly R Lezak; Olivia M Harris; Erin Roelke; Niklas Gick; Inyop Choi; Shaquille Edwards; Emily Wasserman; Donna J Toufexis; Karen M Braas; Victor May; Sayamwong E Hammack
Journal:  Neuropsychopharmacology       Date:  2014-01-17       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.